Ketek May Well Lose Sinusitis And Bronchitis Approval, FDA
Sat, 16 Dec 2006 06:00 PM EST
... Ketek (telithromycin), an antibiotic used to combat pneumonia, as well as treating bronchitis and sinusitis, got an unfavorable review from an FDA Advisory Committee (panel) yesterday. Ketek's pneumonia indication may soon come with a 'black box' warning, while its approval for the treatment of sinusitis and bronchitis will go altogether if the FDA does what the panel recommends. [click link for full article] ...
Related Topics
- Telithromycin
- Bronchitis
- Sinusitis
- Antibiotics
- Vaccine Testing & Approval
- Bronchiolitis
- Hydrocortisone, Neomycin, and Polymyxin Otic
- Chronic sinusitis
- Acute sinusitis
- Tacrolimus ointment
- Choose to Lose
- Eat Great, Lose Weight
- Mammography
- Carcinogens
- Tarceva
- Pimecrolimus Cream 1%
- Dietary Guidelines
- Methimazole
- Thalidomide
- Laryngitis

Not Signed In -


